A new umbrella review brings together more than a decade of evidence on specialist cancer nurse-led care. It finds nurses make their strongest impact in self-management support, symptom management and patient satisfaction, with clear messages for workforce planning.
In this webinar recording, Dr Raquel Ruiz Araujo shares practical insights into recognising and managing these reactions, including those caused by EGFR inhibitors.
From 1 October 2026, Triptorelin 3.75mg (Diphereline®) will become available on the PBS for the treatment of a range of women’s health conditions, including breast cancer, endometriosis and uterine fibrosis.
When is a rash more than just a rash? And what should you be looking for before a patient even tells you something has changed? Available exclusively to CNSA members, we encourage you to login and listen today!
